In Vitro Diagnostic Regulatory & Reimbursement Conference for the EU Market

Creating a Unified Strategy for In Vitro Diagnostic Commercialization: Recognizing the Impact of Regulatory Approvals & Reimbursement on Overall Company Success

February 16-17, 2009
Frankfurt, Germany

IVD (in vitro diagnostics) tests are essential to the practice of health care worldwide: with the EU serving as a rich market. Efforts to harmonize regulations continue, yet companies looking to gain market access must be aware of varying restrictions and approval processes for each state.
With R&D expenses rising for new methodologies, payer perspectives and partnerships with pharmaceuticals are of increasing importance. This meeting will discuss regulatory pathways and the value of diagnostics as well as market access issues, reimbursement, opportunities and risks for innovative products.

This Conference Will Feature:

Current European Regulatory Landscape and a Developing IVD Market

Dr. Maurizio Suppo
Vice President RAQS-EHS
Global Customer Management
Siemens Healthcare Diagnostics

European Reimbursement Case Studies: A Country-by-Country Perspective: Belgium

Gert Matthijs, PhD
Head of the Laboratory for Molecular
Center for Human Genetics

Process Behind Test Evaluation and Evidence-based Assessments

Dr. Sarah Garner
Associate Director, Research and Development
Centre for Health Technology Evaluation-NICE

And Many More...

For full conference agenda, registration details, and infomation on promotional pricing please contact:
Paul Hernandez, Marketing Manager
phernandez@Q1productions.com
312-602-9684